IMCAS China 2025
Program

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Dior puts the science of Reverse Aging at the service of beauty to accelerate research and development of skincare products.

Introduction: If healthy longevity is the ultimate goal, the pathways of Reverse Aging are unanimously recognized by scientific experts as essential players in the aging process.

Results: In this context, Chronic inflammation that we call Skin inflammaging, is one of the 12 hallmarks of aging and it has been addressed for over 20 years by Dior Prestige to rejuvenate the skin in a very efficient manner and is interdependent with the intercellular communication.

Conclusion: This interconnection leads to the discovery of biological pathways on which new extracts from Rose de Granville will act intensely and profoundly to achieve accelerated regeneration.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: This presentation will focus on treatment protocols and techniques for the combined use of HA fillers and PLLA, tailored to different facial aging morphotypes. It will explore product selection, injection strategies, and procedural nuances to achieve natural and harmonious rejuvenation.

Introduction: The combined use of hyaluronic acid (HA) fillers and poly-L-lactic acid (PLLA) presents a promising approach to addressing anatomical disproportions and age-related changes. Traditionally, these products are applied separately in distinct anatomical zones and tissue layers; however, integrating them within a single treatment session can enhance results, providing optimal and long-lasting outcomes.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Lotos United

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Lotos United

Objectives: This course will provide participants with a comprehensive understanding of the core elements and strategies for integrating physician intellectual property (IP) development with clinical device applications. Participants will learn to establish an effective system for personal brand building and clinical technology application.

Introduction: In today's rapidly developing medical aesthetics industry, building a doctor's personal brand has become a key way to increase industry influence and commercial value. This report aims to deeply explore practical strategies for integrating doctor IP with clinical devices. Through case studies of successful IP development, the report reveals how to leverage clinical experience, academic achievements, online traffic management, and brand collaborations to create an IP with an international perspective.

Materials / method: First, to successfully build a doctor's IP, it is necessary to lay a solid professional foundation. Next, focus on online operational strategies and establish a data-driven mindset. Regularly analyze platform data, patient feedback, and market trends to optimize content strategies and commercial cooperation models continuously. By following a systematic IP development path, doctors can enhance their personal brand influence and drive the innovative application of medical technology, ultimately achieving dual enhancement of their professional and commercial value.

Results: Doctors can develop a clear roadmap for their IP development by clearly defining the positioning, model, and team and resource integration of medical aesthetics care companies. Each step must be carefully planned and steadily implemented, from the short-term deepening of the Asian skin database and incubation of a doctor IP matrix to the mid-term launch of co-branded care lines and establishment of an online and offline service network, and finally to the long-term goal of becoming the standard-setter for Asian skin anti-aging and promoting the globalization of medical IP.

Conclusion: Developing a doctor IP requires a systematic approach that focuses on four core elements: clinical experience, brand partnerships, online traffic management, and the latest clinical data. With continuous effort and innovation, a doctor IP's professionalism, commercial value, and market influence can be enhanced.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of:

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: In the present study, we are aimed at creating a hybrid protocol, combining the application injectable poly-L-lactic acid and hyaluronic acid. The protocol has to meet the requirements safety, effecacy, and predictability of clinical results.

Introduction: There are pathological conditions, including scars and striae, as well as normal physiological processes, such as aging, associated with changes in the quality and quantity of collagen fibres in the skin. The possibility of predictable bioregulation of new collagen fibres production is a challenge that both manufacturers of collagen stimulators and dermatologists face whit.

Materials / method: Poly-L-lactic acid and uncrosslinked high molecular weight hyaluronic acid were injected in one zone, at one level, to a certain depth and within one treatment session. Dynamic monitoring was conducted for 6 weeks. Ultrasound study and histological examination of skin biopsies were used to estimate the result of the treatment.

Results: We revealed a common trend including reduction in rehabilitation period and achievement of positive clinical results witch took less time in comparison with the patients who were treated with according to a mono protocol eather whit poly-l-lactic acid or hyaluronic acid . The treatment with a combined protocol allowed as to reduce the number of patients’s visits to the clinic and to get a high level of patients’s satisfaction.

Conclusion: Hybrid protocols combining the application of injectable poly-L-lactic acid and hyaluronic acid are characterized by safety and hight predictable performance.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): LOTOS UNITED

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): LOTOS UNITED

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: LOTOS UNITED

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Yield stress as an innovative parameter for the rheological characterization of cross-linked hydrogel

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: VIVACY

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: 乳酸菌外泌体在皮肤修护领域的应用

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability